Fate Therapeutics Inc

FATE

$39.31

-62.8% last 12 months

Market Cap

$4.03 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$41.88 - $119.85

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-20.49x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $4.03 Billion
Enterprise Value $3.9 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return -62.8%
52-Week High $119.85
52-Week Low $41.88
Beta 1.7
Outstanding Shares 95.5 Million
Avg 30 Day Volume 1.39 Million

Valuation

P/E Ratio -20.49
PEG 78.22
Earnings per Share -$2.12
Price to Sales Ratio Infinity
Price to Book Ratio 5.62
Revenue to Enterprise Value 71.34
EBIT to Enterprise Value -21.55
Total Debt to Enterprise Value 0.0
Debt to Equity 0.0

Profitability

Revenue $54.7 Million
Gross Profit $54.7 Million
EBIT -$181 Million
Net Income -$197 Million
Profit Margin -359.65%
Quarterly Earnings Growth (YoY) -26.2%
Return on Equity -26.92%
Return on Assets -19.97%
Return on Invested Capital -20.28%

Insider trades

No purchases

45,019 shares sold (4 transactions)

No purchases

8,679 shares sold (3 transactions)

No purchases

45,835 shares sold (3 transactions)

No purchases

49,416 shares sold (9 transactions)

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Fate Therapeutics Inc

CEO: William Rastetter

Industry: Biological Product (except Diagnostic) Manufacturing

Similar stocks

Sarepta Therapeutics Inc
Sarepta Therapeutics Inc
Becton, Dickinson And Co.
Becton, Dickinson And Co.
PTC Therapeutics Inc
PTC Therapeutics Inc
Avidity Biosciences Inc
Avidity Biosciences Inc
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.

News